NewsEvents

Your Yourlocation: Home > The efficacy of combined inhaled tiotropium bromide(136310-93-5) and salmeterol fluticasone propionate in the treatment of patients with chronic obstructive pulmonary disease

To observe the clinical effects of combined inhaled tiotropium bromide(136310-93-5) and salmeterol fluticasone propionate in the treatment of patients with chronic obstructive pulmonary disease. Studies have shown that the combination of tiotropium bromide(136310-93-5), salmeterol fluticasone propionate in the treatment of chronic obstructive pulmonary disease has a better clinical effect, can significantly improve the patient's blood gas and lung function, effective control of the deterioration of chronic obstructive pulmonary disease, has a very high clinical value. The article published on "China Practical Medicine".

100 patients with chronic obstructive pulmonary disease were randomly divided into the control group and the observation group, each group of 50 patients in the control group were given a single tiotropium bromide(136310-93-5) powder inhalation treatment, the observation group on this basis, All patients were treated for 3 months as a course of treatment. After treatment, blood gas and pulmonary function recovery were observed in both groups.

After treatment, the observation group in patients with lung function and blood gas indicators were better than the control group, the difference was statistically significant (P <0.05).

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved